Showing results (1-10 of 685) with videos related to
Sort By:
Pageof 69
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1988
[Prostate specific antigen in serum of the patients with prostatic cancer]S Akimoto, K Akakura, H Fuse, et al.Hinyokika Kiyo. Acta Urologica Japonica|July 1, 1987
[Prostatic specific antigen in the serum in prostatic cancer]H Fuse, K Akakura, S Akimoto, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|March 1, 1990
[Spinal paralysis caused by spinal metastasis of prostatic cancer]H Fuse, S Akimoto, K Akakura, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1988
[Treatment of prostatic cancer]J Shimazaki, H Fuse, S Akimoto, et al.Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1988
[Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog]H Fuse, S Akimoto, K Akakura, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Prostatic carcinoma. I: Androgen dependency of prostatic carcinoma]J Shimazaki, H Fuse, S Akimoto, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1996
Pain caused by bone metastasis in endocrine-therapy-refractory prostate cancerK Akakura, S Akimoto, J ShimazakiJapanese Journal of Clinical Oncology|June 1, 1996
Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancerS Akimoto, K Akakura, J ShimazakiHinyokika Kiyo. Acta Urologica Japonica|August 1, 1988
[Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer]S Akimoto, K Akakura, J ShimazakiHinyokika Kiyo. Acta Urologica Japonica|December 1, 1988
[Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer]S Akimoto, K Akakura, J ShimazakiPageof 69